Lodenafil carbonate

Lodenafil carbonate, a dimer that acts as a proagent delivering Lodenafil in vivo, is an orally active phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) [1][2].

Product Specifications

CAS Number

[398507-55-6]

UNSPSC

12352005

Target

Phosphodiesterase (PDE)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Endocrinology

Assay Protocol

https://www.medchemexpress.com/lodenafil-carbonate.html

Purity

98.0

Solubility

10 mM in DMSO

Smiles

CCCC1=NN(C)C2=C1NC(C3=C(C=CC(S(=O)(N4CCN(CCOC(OCCN5CCN(S(=O)(C6=CC(C(NC7=C8N(C)N=C7CCC)=NC8=O)=C(OCC)C=C6)=O)CC5)=O)CC4)=O)=C3)OCC)=NC2=O

Molecular Formula

C47H62N12O11S2

Molecular Weight

1035.20

References & Citations

[1]Glina S, et al. Efficacy and tolerability of lodenafil carbonate for oral therapy in erectile dysfunction: a phase II clinical trial. J Sex Med. 2009 Feb;6 (2) :553-7.|[2]Toque HA, et al. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum. Eur J Pharmacol. 2008 Sep 4;591 (1-3) :189-95.